Hagen Brett R

Chief Accounting Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

97.7%

Avg 3M Return

+23.5%

Avg 12M Return

+61.4%

Hagen Brett R is a Chief Accounting Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $10K based on current market prices.

Holdings by Company

KLRSMar 26, 2025

Current Shares1.9K

Value$9.9K

Net Activity-116,443

Bought: 0Sold: 116.4K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 26, 2025	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	907	$8.97	$8,135.16	-32.0%	-73.0%	-36.8%
Feb 21, 2025	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	96	$10.08	$967.28	-3.3%	-70.6%	+3.8%
Jan 23, 2025	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	36	$9.51	$342.28	-0.6%	-31.2%	-3.8%
Jan 10, 2025	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	332	$0.44	$146.11	-0.5%	-27.6%	-3.2%
Nov 19, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	554	$0.55	$303.87	-0.8%	-25.6%	-48.1%
Nov 5, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	1,655	$0.86	$1,431.41	-2.3%	-57.0%	-78.0%
Oct 22, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	965	$0.77	$746.29	-0.7%	-47.6%	-75.5%
Oct 3, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	301	$0.81	$245.25	-0.4%	-45.0%	-64.7%
Aug 19, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	544	$0.76	$413.17	-0.8%	-24.6%	-85.4%
Aug 5, 2024	KLRS Kalaris Therapeutics, Inc.	Chief Accounting Officer	Sell	1,692	$0.73	$1,243.28	-2.3%	+21.3%	-84.8%